Marketwatch Buy Dr Lal Pathlabs, target price Rs Rs 1,724: ICICI Securities Admin April 1, 2020 The brokerage is positive on the long-term outlook considering the company’s strong brand franchise with sustainable growth, expansion potential, healthy FCFF generation and strong return ratios. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
